Main Library
The Medicare Payment Advisory Commission (MedPAC) proposed streamlining Medicare alternative payment models (APMs), along with policy options for tackling pricey Part B drugs, in its June report to Congress Wednesday.
In the June 2021 report, MedPAC called for reducing the number of Medicare APMs so that models running concurrently could work better together. The 2022 report builds on that idea, offering strategies that “would represent a shift for CMS — moving away from temporarily testing a large number of model tracks on a small scale to permanently operating a small number of model tracks on a large scale.”